| Description | This is a human antibody product that specifically targets the fig mosaic virus (FMV) nucleocapsid protein. The FMV is responsible for causing the widespread mosaic disease. A synthetic construct clone was developed to combat the recombinant nucleocapsid protein of FMV (FMV-Np). |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Fair Market Value (FMV) |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | ELISA |
| Application Notes | SYNT001 (10 nM, 50 nM, and 100 nM; 48 h) suppresses the production of interferon IFN-γ in CD11c+ antigen-presenting cells (APCs) derived from B2MTG/TGFCGRTTG/TGFcgrt-/- mice. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | FMV NP |
| Alternative Name | Fig mosaic emaravirus nucleocapsid protein; Fig mosaic emaravirus; nucleocapsid; FMV; NP; FMV-Np |
| Research Area | Infectious Disease |
